Cocrystal Pharma, Inc. (COCP)
1.53
-0.03 (1.92%)
Upcoming Events
Latest Headlines
Form 10-K/A Cocrystal Pharma, Inc. For: Dec 31
April 17, 2024 5:01 PM - SEC Filing
Form 10-K Cocrystal Pharma, Inc. For: Dec 31
March 28, 2024 8:02 AM - SEC Filing
Form 8-K Cocrystal Pharma, Inc. For: Mar 28
March 28, 2024 8:01 AM - SEC Filing
Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
March 28, 2024 8:00 AM - StreetInsider
Form 8-K Cocrystal Pharma, Inc. For: Mar 19
March 19, 2024 8:31 AM - SEC Filing
Cocrystal Pharma (COCP) Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A
March 19, 2024 8:02 AM - StreetInsider
Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A
March 19, 2024 8:00 AM - StreetInsider
Cocrystal Pharma Discusses Antiviral Therapeutics' Clinical Development and 2024 Value Catalysts in New CEO Video Interview on Planet MicroCap
March 5, 2024 8:34 AM - StreetInsider
Form 8-K Cocrystal Pharma, Inc. For: Feb 28
March 1, 2024 4:16 PM - SEC Filing
Full Article List